NO961189D0 - Salt comprising more than 99.0% by weight sodium chloride, as well as the use of the salt - Google Patents

Salt comprising more than 99.0% by weight sodium chloride, as well as the use of the salt

Info

Publication number
NO961189D0
NO961189D0 NO961189A NO961189A NO961189D0 NO 961189 D0 NO961189 D0 NO 961189D0 NO 961189 A NO961189 A NO 961189A NO 961189 A NO961189 A NO 961189A NO 961189 D0 NO961189 D0 NO 961189D0
Authority
NO
Norway
Prior art keywords
salt
sodium chloride
well
weight sodium
granules
Prior art date
Application number
NO961189A
Other languages
Norwegian (no)
Other versions
NO961189L (en
Inventor
Leon Ninane
Original Assignee
Solvay
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9477467&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO961189(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Solvay filed Critical Solvay
Publication of NO961189D0 publication Critical patent/NO961189D0/en
Publication of NO961189L publication Critical patent/NO961189L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01D—COMPOUNDS OF ALKALI METALS, i.e. LITHIUM, SODIUM, POTASSIUM, RUBIDIUM, CAESIUM, OR FRANCIUM
    • C01D3/00—Halides of sodium, potassium or alkali metals in general
    • C01D3/26—Preventing the absorption of moisture or caking of the crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01D—COMPOUNDS OF ALKALI METALS, i.e. LITHIUM, SODIUM, POTASSIUM, RUBIDIUM, CAESIUM, OR FRANCIUM
    • C01D3/00—Halides of sodium, potassium or alkali metals in general
    • C01D3/22—Preparation in the form of granules, pieces, or other shaped products
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01D—COMPOUNDS OF ALKALI METALS, i.e. LITHIUM, SODIUM, POTASSIUM, RUBIDIUM, CAESIUM, OR FRANCIUM
    • C01D3/00—Halides of sodium, potassium or alkali metals in general
    • C01D3/22—Preparation in the form of granules, pieces, or other shaped products
    • C01D3/24—Influencing the crystallisation process

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Seasonings (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)

Abstract

Salt comprising more than 99.0 wt.% sodium chloride in the form of spheroidal granules with an average dia. of greater than 0.6 mm and less than 3 mm is new. The granules have an average dia. of 1.5-2.2 mm, a granulometric spread of 0.9-3.2 mm and consist of monolithic crystalline blocks. The salt is obtd. by circulating a super-satd. NaCl soln. from bottom to top of a fluidised bed of NaCl crystals.
NO961189A 1995-03-24 1996-03-22 Salt comprising more than 99.0% by weight sodium chloride, as well as the use of the salt NO961189L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9503588A FR2732004B1 (en) 1995-03-24 1995-03-24 SALT COMPRISING SODIUM CHLORIDE AND LESS THAN 5% BY WEIGHT OF WATER AND USE THEREOF

Publications (2)

Publication Number Publication Date
NO961189D0 true NO961189D0 (en) 1996-03-22
NO961189L NO961189L (en) 1996-09-25

Family

ID=9477467

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961189A NO961189L (en) 1995-03-24 1996-03-22 Salt comprising more than 99.0% by weight sodium chloride, as well as the use of the salt

Country Status (11)

Country Link
EP (1) EP0733590B1 (en)
JP (1) JPH08259223A (en)
KR (1) KR100424000B1 (en)
AT (1) ATE211118T1 (en)
CA (1) CA2171174A1 (en)
DE (1) DE69618053T2 (en)
DK (1) DK0733590T3 (en)
ES (1) ES2170193T3 (en)
FR (1) FR2732004B1 (en)
NO (1) NO961189L (en)
PT (1) PT733590E (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2821344B1 (en) * 2001-02-26 2003-04-25 Solvay AGGLOMERATED MINERAL SUBSTANCE GRANULE, RESISTANT TO ABRASION, POWDER COMPRISING SUCH GRANULES AND METHOD FOR THE PRODUCTION THEREOF
ES2468568T3 (en) * 2008-01-07 2014-06-16 Council Of Scientific & Industrial Research Process for preparing spherical crystals of common salt
CN107382380A (en) * 2017-07-27 2017-11-24 蓝德环保科技集团股份有限公司 A kind of method that biological potassium fertilizer is prepared using plant ash
CN107522211B (en) * 2017-08-18 2019-08-09 天津大学 A kind of spherical shape potassium chloride and preparation method thereof
CN111302362B (en) * 2020-04-03 2021-05-07 天津科技大学 Large-particle spherical salt and preparation method thereof
CN113999734A (en) * 2021-10-26 2022-02-01 中盐工程技术研究院有限公司 Dish-washing machine special salt for improving soft water efficiency and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2562884B1 (en) * 1984-04-16 1988-12-30 Solvay PROCESS FOR THE PRODUCTION OF SALT AND SALT OBTAINED THEREBY
JPH01145320A (en) * 1987-11-30 1989-06-07 Japan Tobacco Inc Production of common salt having 8-14-hedron crystal
FR2634665B1 (en) * 1988-07-29 1991-12-13 Solvay PROCESS AND PLANT FOR CRYSTALLIZATION OF A MINERAL SUBSTANCE AND CRYSTALS OF SODIUM CHLORIDE

Also Published As

Publication number Publication date
DE69618053T2 (en) 2002-09-12
ES2170193T3 (en) 2002-08-01
CA2171174A1 (en) 1996-09-25
KR100424000B1 (en) 2004-06-23
DK0733590T3 (en) 2002-04-15
KR960034075A (en) 1996-10-22
EP0733590A1 (en) 1996-09-25
ATE211118T1 (en) 2002-01-15
PT733590E (en) 2002-06-28
JPH08259223A (en) 1996-10-08
FR2732004B1 (en) 1997-05-30
DE69618053D1 (en) 2002-01-31
EP0733590B1 (en) 2001-12-19
FR2732004A1 (en) 1996-09-27
NO961189L (en) 1996-09-25

Similar Documents

Publication Publication Date Title
CA2339792A1 (en) Opthalmic solution with tetracycline for topical treatment of dry eye disease
ES2166379T3 (en) 2-AMINOTETRALINAS REPLACED.
HUP9801872A2 (en) Valaciclovir tablets containing colloidal silicon dioxide and process for producing them
DE69630878D1 (en) GELATIN CAPSULE WITH ADJUSTED WATER ACTIVITY
UA27031A1 (en) 3(2h) pyridazinone derivatives or pharmaceutically acceptable salts thereof, having antithrombotic, positive inotropic, vasodilating effect and antiallergic activity, and the pharmaceutical composition on the basis thereof
ES2098226T3 (en) AQUEOUS OPHTHALMIC SOLUTIONS AND METHOD FOR PRESERVING THEM.
EP0390369A3 (en) Orally administrable ibuprofen compositions
HK1058620A1 (en) Low salt forms of polyallylamine
GR880100532A (en) Thixotropic clay aqueous suspensions containing salt fatty acid stabilizer
NO961189L (en) Salt comprising more than 99.0% by weight sodium chloride, as well as the use of the salt
NO883725L (en) Toothpaste.
ATE73800T1 (en) ANHYDROUS AND CRYSTALLINE SODIUM SALT OF 5-CHLORO-3-(2-THENOYL)-2-OXINDOL-1-CARBOXAMIDE.
KR970707114A (en) The present invention relates to a nerve growth factor (NGF) activity enhancer containing 1,2-ethanediol derivatives or salts thereof.
PL374896A1 (en) A new crystalline form of the sodium salt of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid
Lyczkowski-Shultz et al. Diel vertical distribution of red drum Sciaenops ocellatus larvae in the northcentral Gulf of Mexico.
FI962235A0 (en) Novel benzenesulfonylimine derivatives as inhibitors of IL-1 function
DE69421461D1 (en) Use of a salt composition for salting and preserving meat products
ID28705A (en) COMPOSITION CONSIST OF ASCORBATE ACID AND PEKTIN
CA2020209A1 (en) Low viscosity, highly concentrated surfactant suspension
CA2177146A1 (en) Heterocyclic benzenesulfonylimine derivatives as inhibitors of il-1 action
YU48310B (en) PREMIX FOR ANIMAL FEED
BR8702650A (en) DETERGENT COMPOSITION
ATE43137T1 (en) PRODUCTION OF FREE-FLOWING PARTICULATE YEAST.
USD238594S (en)
GB9107763D0 (en) Substituted furan sulfonamides as antiglaucoma agents

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application